Sorrento Therapeutics
Sorrento Therapeutics was a San Diego biopharmaceutical company developing antibody, cell-therapy, and pain-management programs; its Chapter 11 liquidation plan became effective in April 2024 after operating assets were sold to Vivasor.
Key facts
| Also Known As | Sorrento Therapeutics INC Sorrento Therapeutics |
|---|---|
| Business Model | Commerce |
| Legal Name | Sorrento Therapeutics, Inc. |
| Company Operating Status | Closed |
| Full Address | 4955 Directors Place San Diego, CA 92121 |
| Stock Symbol | FIBR |
| Ticker Symbol | 0L85 |
| Wellfound ID | sorrento-therapeutics-srne |
| Wikidata ID | Q30288730 |
Contact details
Email and phone for Sorrento Therapeutics are available to signed-in members of CliffBio.
Sign in to view